终末期肾脏病血液透析患者肾性贫血的危险因素分析及个性化预防策略探讨

Risk factor analysis and personalized prevention strategies for renal anemia in hemodialysis patients with end-stage kidney disease

  • 摘要:
    目的 探讨终末期肾脏病(ESKD)血液透析患者肾性贫血的危险因素。
    方法 回顾性选取2021年12月—2022年12月于本院行血液透析治疗的148例ESKD患者作为研究对象, 根据血红蛋白(Hb)水平的不同及肾性贫血诊断标准将患者分为肾性贫血组(86例)和非贫血组(62例)。比较2组临床资料。采用随机森林算法及多因素Logistic回归分析筛选影响肾性贫血的因素,并建立多因素Logistic回归模型,同时采用十字交叉试验验证模型的稳定性。建立风险分层系统,并根据X-Tile软件获得的截断值对患者进行风险分层。采用受试者工作特征(ROC)曲线评价多因素Logistic回归模型和风险分层系统的区分度。
    结果 148例ESKD患者中,肾性贫血发生率为58.11%(86/148); 高血压、中性粒细胞与淋巴细胞比值(NLR)增加、C反应蛋白(CRP)升高、血清铁蛋白(SF)升高、全段甲状旁腺激素(iPTH)升高是影响患者肾性贫血发生的危险因素(P < 0.05), 服用α-骨化醇、促红细胞生成素(EPO)升高、甘油三酯(TG)升高、血清白蛋白(ALB)升高是保护因素(P < 0.05)。多因素Logistic回归模型的拟合优度检验结果显示Nagelkerke R2=0.593。根据X-Tile软件获得风险评分的截断值,将患者分为低危组(< 4分, 29例)、中危组(4~ < 7分, 64例)和高危组(≥7分, 55例), 肾性贫血发生率分别为24.14%、57.81%和76.36%。3组肾性贫血发生率比较,差异有统计学意义(P < 0.001)。训练集中多因素Logistic回归模型和风险分层系统的ROC曲线的曲线下面积分别为0.826、0.811, 验证集中分别为0.804和0.789。
    结论 ESKD血液透析患者肾性贫血的发生受高血压、NLR、CRP等诸多因素的影响。

     

    Abstract:
    Objective To explore the risk factors for renal anemia in hemodialysis patients with end-stage kidney disease (ESKD).
    Methods A total of 48 ESKD patients undergoing hemodialysis in our hospital from December 2021 to December 2022 were selected as study objects. They were divided into renal anemia group (86 cases) and non-anemia group (62 cases) based on hemoglobin (Hb) levels and diagnostic criteria for renal anemia. Clinical data between the two groups were compared. Random forest algorithm and multivariate Logistic regression analysis were used to screen for factors influencing renal anemia, and a multivariate Logistic regression model was established. Cross-validation was also employed to verify the stability of the model. A risk stratification system was developed, and patients were stratified based on cut-off values obtained from X-Tile software. The areas under the receiver operating characteristic (ROC) curves were used to evaluate the discrimination ability of the multivariate Logistic regression model and the risk stratification system.
    Results Among 148 ESKD patients, the incidence of renal anemia was 58.11% (86/148). Hypertension, increased neutrophil-to-lymphocyte ratio (NLR), elevated C-reactive protein (CRP), increased serum ferritin (SF), and elevated intact parathyroid hormone (iPTH) were identified as risk factors for renal anemia (P < 0.05). Administration of α-calcidol, increased erythropoietin (EPO), elevated triglyceride (TG), and increased serum albumin (ALB) were protective factors (P < 0.05). The goodness-of-fit test for the multivariate Logistic regression model showed a Nagelkerke R2 of 0.593. Based on the cut-off values for risk scores obtained from X-Tile software, patients were stratified into low-risk group (< 4 points, 29 cases), medium-risk group (4 to < 7 points, 64 cases), and high-risk group (≥7 points, 55 cases), with renal anemia incidence rates of 24.14%, 57.81%, and 76.36%, respectively. The difference in renal anemia incidence rates among the three groups was statistically significant (P < 0.001). In the training set, the areas under the ROC curves for the multivariate Logistic regression model and the risk stratification system were 0.826 and 0.811, respectively, and were 0.804 and 0.789, respectively in the validation set.
    Conclusion The occurrence of renal anemia in hemodialysis patients with ESKD is influenced by various factors, including hypertension, NLR, CRP, etc.

     

/

返回文章
返回